Compensation for Immunotherapy: The End of the Beginning

Michael Rawlinson QC has written a paper about awards for immunotherapy treatment in mesothelioma claims. In particular, he writes about the different forms such awards can take, having acted in two cases which settled last week in which the awards were compromised on different bases: one in the form of a variable PPO, and the other as a ‘float’ agreement. The paper can be read here.

Regular readers of this blog will recall that Michael has previously written about this topic. For those that missed it, the post can be viewed here.


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.